IL10 and type 1 diabetes mellitus: Loss of IL-10 production by Foxp3+ Tregs has been correlated with disease progression in a NOD model of type 1 diabetes (48), and disruption of IL-10 expression in Foxp3+ Tregs led to spontaneous colitis and augmented immune-response related inflammation in the skin and lungs of mice (49).